Status:
COMPLETED
Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome
Lead Sponsor:
Nishtar Medical University
Conditions:
Nephrotic Syndrome
Eligibility:
All Genders
1-10 years
Phase:
NA
Brief Summary
The investigators planned this research to elucidate if there is any efficacy of montelukast, a leukotriene receptor antagonist, in steroid sensitive childhood onset NS to help prevent relapses. This ...
Detailed Description
A quasi-experimental study, done at Department of Pediatric Nephrology at the Children's Hospital \& the Institute of Child Health, Multan. A total of 96 patients aged 1-10 years with steroid sensitiv...
Eligibility Criteria
Inclusion
- A total of 106 children aged 1-10 years with idiopathic nephrotic syndrome were enrolled
- \-
Exclusion
- Patients having Steroid resistant nephrotic syndrome (SRNS) or those having nephrotic syndrome with atypical features or Secondary cause were excluded.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04818723
Start Date
February 1 2019
End Date
May 30 2020
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatric Nephrology, The Children's Hospital and Institute of Child Health
Multan, PPunjab, Pakistan